EVALUATING THE ROLE OF IMMATURE PLATELET FRACTION IN PLATELET ENGRAFTMENT IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
DOI:
https://doi.org/10.71000/rq5q1932Keywords:
Immature Platelet Fraction, Platelet Engraftment, Hematopoietic Stem Cell Transplantation, Biomarker, Platelet Recovery.Abstract
Background: Hematopoietic stem cell transplantation (HSCT) is a bone marrow condition in which platelet engraftment is a vital indicator of the condition. The immature platelet fraction (IPF) refers to the percentage composition of the recently formed platelets and could be used as a biomarker of prognosis of platelet recovery. The objective of this study was to conduct a test concerning the application of IPF in the measurement of the platelet engraftment in patients in the HSCT.
Methods: The study was a descriptive one that took place within a 6 months time span in Shifa International Hospital. The consecutive sampling method was used to select the patients who underwent allogeneic or autologous transplantation of severe hematological disorders with the age of 30 between 15-60 years. Cases with grafted versus disease and other cases who were not of the age bracket were disqualified. To determine the relationship between platelet engraftment and IPF, as well as platelet count, on days 9 and 14 after the transplant, IPF and platelet counts were measured. Paired t-tests, ANOVA, and chi-square tests were used to perform the statistical analysis and the p-value below 0.05 was used to accept the significance.
Results: It was revealed that IPF rose significantly in day 9 (4.35 ± 1.46%) to day 14 (5.68 ± 2.26) following HSCT (t = 3.21, p = 0.004) indicating that there was active platelet production in the early engraftment. The platelet measures were on an increasing trend and it was in agreement with increments of IPF. There were differences in age between the time of platelet engraftment (F = 5.48, p = 0.009) with the young patients (15-30 years old) having a higher platelet engraftment rate (9.2 ± 1.5 days) than the old patients. It further was discovered that, gender difference was critical, and the male engrafted far earlier (9.5 ± 1.6 days) in comparison to the female (10.8 ± 2.1 days) (t = 2.12, p = 0.043).
Conclusion: IPF results are the basis of support that the platelet engraftment prediction and follow-up after HSCT are a useful biomarker. Platelet counts and IPF follow-up can potentially be used to improve clinical care, such as early detection of platelet recovery and transfusiveness. In other studies, the cohort size must be larger to confirm these findings.
References
Chang YJ, Pei XY, Huang XJ. Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions. Lancet Haematol. 2022 Dec;9(12):e919-e929.
Migdady Y, Pang Y, Kalsi SS, Childs R, Arai S. Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics. Blood Adv. 2022 Apr 26;6(8):2707-2721.
Steibel K, Joris M, Clichet V, Charbonnier A, Desoutter J, Marolleau JP, Garçon L, Boyer T. Evaluation of the immature platelet fraction as a predictive marker of bone marrow regeneration after hematopoietic stem cell transplantation. Int J Lab Hematol. 2025 Feb;47(1):41-50.
Bukhari AA, Durrani M, Khan Z, Shafiq M, Tauqir S, ur Rehman A. Urinary excretion of electrolytes and their correlation with clinical parameters in chronic kidney disease. Journal of Rehman Medical Institute. 2020 Jul 10;6(2):08-11.
Zulfania Z, Hayat H, Mahmood R, Bukhari AA, Ihtesham Y, Rasool U. COMPARISON OF PLATELET INDICES IN HYPOPRODUCTIVE AND HYPERDESTRUCTIVE THROMBOCYTOPENIA. Pakistan Journal of Physiology. 2021 Jun 30;17(2):3-6.
Zhang X, Li M, Zhao A, Dong H, Liang X. Cofilin participates in regulating alpha-epithelial sodium channel by interaction with 14-3-3 isoforms. J Biomed Res. 2020 Sep;34(5):351–360.
Kayano SS, Santana PV, Colella R, Colella MP, Caruso P. Lower platelet count and metastatic tumor are associated with increased risk of spontaneous bleeding in critically ill patients with cancer: An observational study. Transfusion. 2023 Dec;63(12):2311-2320.
Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021 Jan;73(1):366-413.
Bukhari AA, Shaikh AR, Salman W, Bhatti FA, Malik W, Minhas M, Muddasser A, Khaliq H. Pathophysiological role of nerve growth factor (NGF) in asthma: insights into airway inflammation, remodeling, and neural regulation in intensive care settings. Anaesth. pain intensive care. 2025;29(3):681-689.
Kausar R, Batool A, Bukhari AA, Shaikh AR, Aleem A, Minhas M, Hussain M. Crosslinking Salivary Diagnosis with Non-Invasive Insights to Oral Pathology: Novel Systematic Insights to Personalized Medicine in Disease Management. . Pak Armed Forces Med J 2025; 75(3): 611-616.
Goel G, Semwal S, Khare A, Joshi D, Amerneni CK, Pakhare A, Kapoor N. Immature Platelet Fraction: Its Clinical Utility in Thrombocytopenia Patients. J Lab Physicians. 2021 Sep;13(3):214-218.
Birocchi S, Podda GM, Manzoni M, Casazza G, Cattaneo M. Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review. Platelets. 2021 Feb 17;32(2):216-226.
Yang TH, Tsai CK, Wang HY, Ko PS, Chien SH, Lin TA, Chen WC, Hsu TL, Yeh CM, Lu CI, Lin WJ, Chen YJ, Liu CJ, Liu CY. Early prediction of platelet recovery with immature platelet fraction in patients receiving hematopoietic stem cell transplantation. Ann Hematol. 2024 Nov;103(11):4661-4670.
Balci A, Düz ME, Vurmaz A, Çilekar Ş, Kaya F. Comprehensive biomarker analysis of patients with idiopathic pulmonary fibrosis and interstitial lung disease with healthy individuals. Eur Rev Med Pharmacol Sci. 2023 Jun;27(12):5468-5479.
Stainer A, Faverio P, Busnelli S, Catalano M, Della Zoppa M, Marruchella A, Pesci A, Luppi F. Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions. Int J Mol Sci. 2021 Jun 10;22(12):6255.
Li J, Li Y, Ouyang J, Zhang F, Liang C, Ye Z, Chen S, Cheng J. Immature platelet fraction related parameters in the differential diagnosis of thrombocytopenia. Platelets. 2020 Aug 17;31(6):771-776.
Grabek J, D'Elia N, Kelsey G. Immature platelet fraction as a predictor of platelet count recovery following allogeneic bone marrow transplantation. Pathology. 2021 Jun;53(4):493-497.
Georgakopoulou VE. Optimizing patient outcomes in interstitial lung disease through pre- and post-transplant management strategies. World J Transplant. 2025 Sep 18;15(3):101866.
Tentori CA, Gregorio C, Robin M, Gagelmann N, Gurnari C, Ball S, Caballero Berrocal JC, Lanino L. Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes. J Clin Oncol. 2024 Aug 20;42(24):2873-2886.
Salvador C, Meryk A, Hetzer B, Bargehr C, Kropshofer G, Meister B, Anliker M, Crazzolara R. Immature platelet fraction predicts early marrow recovery after severe chemotherapy associated neutropenia. Sci Rep. 2023 Feb 27;13(1):3371.
Pirabe A, Frühwirth S, Brunnthaler L, Hackl H, Schmuckenschlager A, Schrottmaier WC, Assinger A. Age-Dependent Surface Receptor Expression Patterns in Immature Versus Mature Platelets in Mouse Models of Regenerative Thrombocytopenia. Cells. 2023 Oct 8;12(19):2419.
Ortolá-Alonso P, Santacatalina-Roig E, Chover-Sierra E, Merelles-Tormo A, Ballestar-Tarín ML, Martínez-Sabater A. Hematopoietic Stem Cell Transplantation Impact on Patients' Perceived Quality of Life: A Longitudinal Study. Nurs Rep. 2024 Jan 18;14(1):197-211.
Wang Q, Qian W, Han Y, Mao Y, Gao Z, Chen Y, Zeng X, Lu H, Jiang L, Li J, Gu N, Qian P. Ferumoxytol promotes haematopoietic stem cell post-injury regeneration as a reactive oxygen species scavenger. Nat Nanotechnol. 2025 Jul;20(7):959-969.
Sciarra F, Campolo F, Franceschini E, Carlomagno F, Venneri MA. Gender-Specific Impact of Sex Hormones on the Immune System. Int J Mol Sci. 2023 Mar 27;24(7):6302.
Zhang X, Ge Y, Bukhari AA, Zhu Q, Shen Y, Li M, Sun H, Su D, Liang X. Estrogen negatively regulates the renal epithelial sodium channel (ENaC) by promoting Derlin-1 expression and AMPK activation. Experimental & Molecular Medicine. 2019 May;51(5):1-2.
Stomper J, Niroula A, Belizaire R, McConkey M, Bandaru TS, Ebert BL. Sex differences in DNMT3A-mutant clonal hematopoiesis and the effects of estrogen. Cell Rep. 2025 Apr 22;44(4):115494.
Ravindranath MH, El Hilali F, Filippone EJ. The Impact of Inflammation on the Immune Responses to Transplantation: Tolerance or Rejection? Front Immunol. 2021 Nov 22;12:667834.
Zhang Y, Wang Z, Zhou P, Zhang H. From reticulated platelets to immature platelet fraction: structure, function, and clinical applications. Platelets. 2025 Dec;36(1):2467383.
Jeon K, Kim M, Lee J, Lee JS, Kim HS, Kang HJ, Lee YK. Immature platelet fraction: A useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery. Medicine (Baltimore). 2020 Feb;99(7):e19096.
Zucker ML, Murphy CA, Rachel JM, Martinez GA, Abhyankar S, McGuirk JP, Reid KJ, Plapp FV. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Lab Hematol. 2006;12(3):125-30.
Van De Wyngaert Z, Fournier E, Bera E, Carrette M, Soenen V, Gauthier J, Preudhomme C, Boyer T. Immature platelet fraction (IPF): A reliable tool to predict peripheral thrombocytopenia. Curr Res Transl Med. 2020 Jan;68(1):37-42.
Sakuragi M, Hayashi S, Maruyama M, Kiyokawa T, Nagamine K, Fujita J, Maeda T, Kato H, Kashiwagi H, Kanakura Y, Tomiyama Y. Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation. Int J Hematol. 2018 Mar;107(3):320-326.
Hennel E, Kentouche K, Beck J, Kiehntopf M, Boeer K. Immature platelet fraction as marker for platelet recovery after stem cell transplantation in children. Clin Biochem. 2012 Jul;45(10-11):749-52.
Wetzel D, Mueller BU, Mansouri Taleghani B, Baerlocher GM, Seipel K, Leibundgut K, Pabst T. Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia. Br J Haematol. 2015 Jan;168(2):268-73.
Bai L, Xia W, Wong K, Reid C, Ward C, Greenwood M. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre. Ann Hematol. 2014 Oct;93(10):1655-64.
Soubani AO. Critical care considerations of hematopoietic stem cell transplantation. Crit Care Med. 2006 Sep;34(9 Suppl):S251-67.
Mohanraj L, Sargent L, Elswick RK Jr, Toor A, Swift-Scanlan T. Factors Affecting Quality of Life in Patients Receiving Autologous Hematopoietic Stem Cell Transplantation. Cancer Nurs. 2022 Mar-Apr 01;45(2):E552-E559.
Parveen N, Bukhari AA, Khan Z, Mahmood R, Khan K, Ihtesham Y. Association of diabetic retinopathy with dyslipidemia: a multicenter study. J Rehman Med Inst.. 2018;4(4):21-24.
Bukhari AA, Parveen N, Khan Q, Khan K. Leptin levels in vitreous fluids of patients with diabetic retinopathy. Journal of Rehman Medical Institute. 2015;1(1):17-20.
Bukhari AA, Parveen N, Khan Q, Khan K. LEVELS OF SERUM INTERLEUKIN IL-6 IN PATIENTS WITH ADVANCED DIABETIC RETINOPATHY. Journal of Rehman Medical Institute. 2015;1(1):4-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Maria Saeed, Shawana Shahid, Fatima tuz Zahra , Maymoona Suhail, Tuba Farhat, Maira Ijaz, Haseeb Khaliq (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
